A Greenfern Industries nomeia Kirsten Taylor presidente do conselho e Elizabeth Plant CEO para impulsionar o crescimento da cannabis medicinal. Greenfern Industries names Kirsten Taylor board chair and Elizabeth Plant CEO to drive medicinal cannabis growth.

A Greenfern Industries, uma empresa de cannabis medicinal da Nova Zelândia, nomeou Kirsten Taylor como sua nova presidente do conselho e Elizabeth Plant como CEO. Greenfern Industries, a New Zealand medicinal cannabis company, has appointed Kirsten Taylor as its new board chair and Elizabeth Plant as CEO. Taylor traz experiência em governança e inovação de produtos, enquanto Plant, ex-diretor médico da EQUALIS Pharmaceuticals, tem ampla experiência em saúde. Taylor brings expertise in governance and product innovation, while Plant, formerly Chief Medical Officer at EQALIS Pharmaceuticals, has extensive healthcare experience. Eles visam expandir os fluxos de receita e desenvolver produtos inovadores de cannabis medicinal. They aim to expand revenue streams and develop innovative medicinal cannabis products.